Table 1.
Texas (N = 296, 58%) | New York state (N = 218, 42%) | p value** | |
---|---|---|---|
Female, n (%) | 165 (56.3) | 103 (48.1) | 0.068 |
Age, median (IQR), years | 57 (47–66) | 63 (51–77) | <0.001 |
Age group, n (%) | |||
<40 years | 49 (16.6) | 31 (14.2) | <0.001 |
40–49 years | 46 (15.5) | 20 (9.2) | |
50–59 years | 77 (26.0) | 37 (17.0) | |
60–69 years | 62 (21.0) | 48 (22.0) | |
70–79 years | 42 (14.2) | 38 (17.4) | |
80+ years | 20 (6.8) | 44 (20.2) | |
Race, n (%) | |||
White | 146 (49.3) | 156 (71.6) | <0.001 |
Black | 88 (29.7) | 24 (11) | |
Asian | 9 (3.0) | 7 (3.2) | |
Other | 53 (17.9) | 31 (14.2) | |
Hispanic ethnicity, n (%) | 127 (43.2) | 14 (6.6) | <0.001 |
BMI, median (IQR), kg/m2 | 30.3 (25.9–35.9) | 28.49 (24.5–34.01) | 0.015 |
Insurance, n (%) | |||
Private | 97 (33.0) | 50 (23.1) | <0.001 |
Medicare | 65 (22.1) | 93 (43.1) | |
Medicaid | 14 (4.8) | 49 (22.7) | |
Uninsured | 65 (22.1) | 3 (1.4) | |
Positive history of, n (%) | |||
HTN | 174 (58.8) | 112 (51.4) | 0.095 |
HF | 31 (10.5) | 26 (11.9) | 0.604 |
CAD | 30 (10.1) | 41 (18.8) | 0.005 |
Afib | 14 (4.7) | 23 (10.6) | 0.012 |
Stroke | 20 (6.8) | 21 (9.6) | 0.234 |
DM | 121 (40.9) | 66 (30.3) | 0.014 |
Lung disease | 34 (11.5) | 33 (15.1) | 0.224 |
DLD | 93 (31.4) | 61 (28.0) | 0.400 |
Cancer | 13 (4.4) | 19 (8.7) | 0.045 |
Smoking exposure | 87 (33.0) | 65 (30.0) | 0.481 |
COVID-19, coronavirus disease 2019; IQR, interquartile range; HTN, hypertension; HF, heart failure; CAD, coronary artery disease; Afib, atrial fibrillation; DM, diabetes mellitus; DLD, dyslipidemia.
p values from χ2 tests, except for age and BMI (Mann-Whitney test).